Seviteronel
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Seviteronel, covering 2019-02-01 to 2025-05-15. Get the full timeline:
Most recent: Clinical Trial Update: Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer [Phase 1, Phase 2]